1Pfaller MA, Diekema DJ.Epidemiology of invasive candi- diasis: a persistent public health problem[J].Clin Microbi- ol Rev, 2007,20(1) : 133. 被引量：1
2Lewis RE.Pharmacodynamic implications for use of anti- fungal agents[J].Curr Opin Pharmacol, 2007,7 ( 5 ) : 491. 被引量：1
3Andes D.Pharmacokinetics and pharmacodynamics of anti- fungals[J].lnfect Dis Clin North Am, 2006,20 (3) : 679. 被引量：1
4Lepak AJ, Andes DR.Antifungal PK/PD considerations in fungal pulmonary infeetions[J].Semin Respir Crit Care Med, 2011,32(6) : 783. 被引量：1
5Sinnollareddy M, Peake SL, Roberts MS, et al.Using phar- macokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review[J]. Int JAntimicrob Agents, 2012,39 ( 1 ) : 1. 被引量：1
6Heintz BH, Matzke GR, Dager WE.Antimicrobial dosing concepts and recommendations for critically ill adult pa- tients receiving continuous renal replacement therapy or intermittent hemodialysis[J] .Pharmacotherapy, 2009, 29 (5) :562. 被引量：1
9Manavathu EK, Ramesh MS, Baskaran I, et al.A compara- tive study of the post-antifungal effect (PAFE) of ampho- tericin B, triazoles and echinocandins on Aspergillus fu- migatus and Candida albicans[J]. J Antimierob Chemoth- er, 2004,53 (2) : 386. 被引量：1
10Cota J, Burgess D.Antifungal dose adjustment in renal and hepatic dysfunction: pharmacokinetic and pharmacody- namic considerations[J]. Current Fungal Infection Re- ports,2010,4(2) : 120. 被引量：1
6Eagle H,Fleischman R,Musselman AD.Effect of schedule of administration on the therapeutic efficacy of penicillin;importance of the aggregate time penicillin remains at effectively bactericidal levels[J].Am J Med,1950,9(3):280-299. 被引量：1
7Craig WA.Pharmacokinetic/pharmacodynamic parameters:rationale for antibacterial dosing of mice and men[J].Clin Infect Dis,1998,26(1):1-10. 被引量：1
8Shah PM,Junghanns,Stille W.Bactericidal dosie-activity relationships with E.coli,K.pneumoniae and Staph.aureus(author's transl)[J].Dtsch Med Wochenschr,1976,101(9):325-328. 被引量：1
9Kuti JL,Nicolau DP.Making the most of surveillance studies:summary of the OPTAMA Program[J].Diagn Microbiol Infect Dis,2005,53(4):281-287. 被引量：1
10Owens RC Jr,Am brose PG,Nightingale CH.Antibiotic Optimization.Concepts and strategies in clinical practice[M].New York:Marced Dekker,2005:491-518. 被引量：1
